Le Lézard
Classified in: Health, Business
Subject: ATY

Robbins Arroyo LLP Is Investigating Regeneron Pharmaceuticals, Inc. (REGN) Officials on Behalf of Shareholders



SAN DIEGO and TARRYTOWN, N.Y., July 1, 2015 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. Regeneron Pharmaceuticals develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide.

Robbins Arroyo LLP.

View this press release on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/regeneron-pharmaceuticals-inc  

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to www.robbinsarroyo.com.  

Attorney Advertising. Past results do not guarantee a similar outcome.  

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36754LOGO

 

SOURCE Robbins Arroyo LLP


These press releases may also interest you

at 14:58
People with tremors in their hands from a condition called essential tremor may find some relief from a new, non-invasive type of nerve stimulation, according to a preliminary scientific abstract released today that will be presented at the American...

at 12:05
Promius Pharma LLC announces its presentations for the 70th American Academy of Neurology (AAN) Annual Meeting in Los Angeles, CA, April 21-27, 2018. Promius will present 3 platform presentations, with one presentation selected for the "Best of"...

at 11:30
Global pharmaceutical company Mylan N.V. today announced three scientific abstracts from the Glatiramer Acetate development program will be presented at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, April 21-27. The...

at 10:00
Laborie Medical Technologies ("Laborie") announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of LM US Parent, Inc. ("Parent") to purchase all outstanding shares of...

at 10:00
Injured veterans and their guests enjoyed the last days of winter as they gathered with other warriors to ski cross-country with Wounded Warrior Project® (WWP). "We liked it so much, we're planning on going back on our...

at 09:52
Addressing a standing-room-only audience at Children's National Health System and hundreds more viewing remotely, Sri Sri Ravi Shankar says that people often work to create wealth and, in exchange, lose half their health. Then, they spend half their...




News published on 1 july 2015 at 15:21 and distributed by: